Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

SSE:603168.SS

7.68 (CNY) • At close June 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 483.96644.97549.537629.765358.231515.957607.438938.883978.732921.671765.582628.141544.758408.681272.552174.535146.516
Cost of Revenue 246.127288.117227.893224.665184.222174.139169.36213.525230.339242.965224.795194.246180.847137.544110.33289.18987.052
Gross Profit 237.833356.853321.644405.099174.009341.818438.078725.358748.393678.706540.787433.895363.91271.137162.2285.34759.464
Gross Profit Ratio 0.4910.5530.5850.6430.4860.6620.7210.7730.7650.7360.7060.6910.6680.6630.5950.4890.406
Reseach & Development Expenses 57.57764.44959.615102.21427.80126.98926.56229.23529.02431.21127.98122.34418.33513.567000
General & Administrative Expenses 81.7692.63576.91885.34658.40443.25653.70242.37830.71825.17214.68712.3912.66913.28823.2717.66712.607
Selling & Marketing Expenses 56.181135.33493.275116.364149.136249.736290.44410.182423.206395.659320.14257.245211.063150.25182.66840.77421.51
SG&A 137.941226.427170.194201.71207.54292.991344.142452.56453.924420.831334.827269.635223.731163.539105.93858.44234.117
Other Expenses 154.24543.93944.62753.93331.31313.53918.7178.67491.5352.8779.3787.58.7799.0480.2770.1850.009
Operating Expenses 349.763334.815274.436357.857266.654333.519395.891504.832508.289474.019387.6310.065257.992189.714109.25560.35335.425
Operating Income -111.93122.03956.80854.92228.7846.293-130.261178.105234.359205.794147.934118.59699.58677.24850.2121.89720.89
Operating Income Ratio -0.2310.0340.1030.0870.080.09-0.2140.190.2390.2230.1930.1890.1830.1890.1840.1250.143
Total Other Income Expenses Net -3.64311.04-1.609-6.04822.89728.15818.7178.67486.8032.8574.4982.2633.0554.6160.2770.169-0.043
Income Before Tax -115.57433.07855.19848.874-176.50616.782-111.545186.779321.128208.651152.433120.859102.64181.86450.48722.06620.847
Income Before Tax Ratio -0.2390.0510.10.078-0.4930.033-0.1840.1990.3280.2260.1990.1920.1880.20.1850.1260.142
Income Tax Expense 5.927.9749.2613.2182.8648.92514.9340.42245.41132.61521.16316.77611.75513.9527.3922.9822.79
Net Income -123.44325.40844.75235.656-179.3697.857-126.474146.356275.717176.036131.27104.08290.88667.91343.09519.08418.057
Net Income Ratio -0.2550.0390.0810.057-0.5010.015-0.2080.1560.2820.1910.1710.1660.1670.1660.1580.1090.123
EPS -0.330.070.140.11-0.560.024-0.390.450.930.590.510.470.410.310.190.0860.081
EPS Diluted -0.330.070.140.11-0.560.024-0.390.450.930.590.510.470.410.310.190.0860.081
EBITDA -36.319111.253127.039114.1610.11864.39394.881236.86369.421236.287183.314139.077126.405104.26662.82334.2732.441
EBITDA Ratio -0.0750.1720.2310.18100.1250.1560.2520.3770.2560.2390.2210.2320.2550.230.1960.221